General MedicationsORALStandard

AMOXICILLIN AND CLAVULANATE POTASSIUM

AMOXICILLIN; CLAVULANATE POTASSIUM

Standard Dose

250MG/5ML;EQ 62.5MG BASE/5ML

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview AMOXICILLIN AND CLAVULANATE POTASSIUM is listed in Drugs@FDA under application 210374 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient AMOXICILLIN; CLAVULANATE POTASSIUM Form and strength FOR SUSPENSION;ORAL - 250MG/5ML;EQ 62.5MG BASE/5ML Sponsor DEVA HOLDING AS Submission history Latest submission status date: 2023-11-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMOXICILLIN AND CLAVULANATE POTASSIUM is listed in Drugs@FDA under application 210374 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient AMOXICILLIN; CLAVULANATE POTASSIUM Form and strength FOR SUSPENSION;ORAL - 250MG/5ML;EQ 62.5MG BASE/5ML Sponsor DEVA HOLDING AS Submission history Latest submission status date: 2023-11-29 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.